Skip to main content
SpringerLink
Log in

New Frontiers in Endocrinology of Eating Disorders

  • Chapter
  • First Online:
Behavioral Neurobiology of Eating Disorders

Part of the book series: Current Topics in Behavioral Neurosciences ((CTBN,volume 6))

Abstract

Alterations of both central and peripheral feeding regulatory substances occur in the acute phases of anorexia nervosa (AN) and bulimia nervosa (BN) and, generally, reverse after recovery. Some of these alterations are believed not only to sustain the altered eating behavior but also to contribute to certain psychopathological aspects and/or etiopathogenetic processes of eating disorders (EDs). It has been suggested that EDs are clinical conditions linked to reward-related mechanisms leading to a kind of addiction to self-starvation and/or overeating. Most of the feeding regulatory substances, which are dysregulated in EDs, are also implicated in the modulation of reward, emotional, and cognitive functions, thus representing possible links between altered nutritional regulation, motivated behaviors and reward processes. In this chapter, the ED literature dealing with ghrelin, brain-derived neurotrophic factor, opioid peptides, and endocannabinoids, which have prominent effects on eating behavior, body weight, reward, emotional, and cognitive functions, is reviewed in view of the above suggested links. Moreover, the potential therapeutics of new medications developed on the basis of neuroendocrine aberrations found in EDs is also presented.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

β-EP:

Beta-endorphin

2-AG:

2-Arachidonoylglycerol

AEA:

Anandamide

AN:

Anorexia nervosa

ANBP:

Anorexia nervosa binge-purging

ANR:

Anorexia nervosa restricting

BDNF:

Brain-derived neurotrophic factor

BN:

Bulimia nervosa

BW:

Body weight

CCK:

Cholecystokinin

CSF:

Cerebrospinal fluid

ED:

Eating disorder

OLA:

Opiate like activity

References

  • Arosio M, Ronchi CL, Beck-Peccoz P et al (2004) Effects of modified sham feeding on ghrelin levels in healthy human subjects. J Clin Endocrinol Metab 89:5101–5104

    CAS  PubMed  Google Scholar 

  • Asakawa A, Inui A, Fujimiya M et al (2005) Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 54:18–24

    CAS  PubMed  Google Scholar 

  • Baranowska B (1990) Are disturbances in opioid and adrenergic systems involved in the hormonal dysfunction of anorexia nervosa. Psychoneuroendocrinology 15:371–379

    CAS  PubMed  Google Scholar 

  • Beriohay B, Lebrun B, Moyse E et al (2005) Brain-derived neurotrophic factor plays a role as an anorexigenic factor in the dorsal vagal complex. Endocrinology 146:5612–5620

    Google Scholar 

  • Berridge KC (1997) Brain reward systems for food incentives hedonics in normal appetite and eating disorders. In: Kirkham TC, Cooper SJ (eds) Appetite and body weight: integrative systems and the development of anti-obesity drugs. Academic Press, Burlington

    Google Scholar 

  • Berridge KC, Robinson TE (1998) What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28:309–369

    CAS  PubMed  Google Scholar 

  • Berry EM (2006) Pilot study of THC (2.5 mg x 2) in 9 ambulatory AN patients (abstract). In: The sixth nordic congress on eating disorders, Aarhus, Denmark

    Google Scholar 

  • Brambilla F, Ferrari E, Petraglia F et al (1991) Peripheral opioid secretory pattern in anorexia nervosa. Psychiatry Res 39:115–127

    CAS  PubMed  Google Scholar 

  • Brambilla F, Monteleone P, Maj M (2008) Central and peripheral peptide regulation of hunger, satiety and food intake in eating disorders. In: Czerbska MT (ed) Psychoneuroendocrinology research trends. Nova Biomedical Books, New York

    Google Scholar 

  • Brewerton TD, Lydiard RB, Laraia MT et al (1992) CSF-β-endorphin and dynorphin in bulimia nervosa. Am J Psychiatry 149:1086–1090

    CAS  PubMed  Google Scholar 

  • Broglio F, Gianotti L, Destefanis S et al (2004) The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clin Endocrinol (Oxf) 60:592–599

    CAS  Google Scholar 

  • Chen CY, Inui A, Asakawa A et al (2005) Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 129:8–25

    CAS  PubMed  Google Scholar 

  • Cota D, Marsicano G, Tschop M et al (2003a) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112:423–431

    CAS  PubMed  Google Scholar 

  • Cota D, Marsicano G, Lutz B et al (2003b) Endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord 27:289–301

    CAS  PubMed  Google Scholar 

  • Cummings DE, Purnell JQ, Frayo RS et al (2001) A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714–1719

    CAS  PubMed  Google Scholar 

  • Di Marzo V, Goparaju SK, Wang L et al (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822–825

    PubMed  Google Scholar 

  • Diano S, Farr SA, Benoit SC et al (2006) Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 9:381–388

    CAS  PubMed  Google Scholar 

  • Ehrlich S, Salbach-Andrae H, Eckart S et al (2009) Serum brain-derived neurotrophic factor and peripheral indicators of the serotonin system in underweight and weight-recovered adolescent girls and women with anorexia nervosa. J Psychiatry Neurosci 34(4):323–329

    PubMed  Google Scholar 

  • Fladung AK, Grön G, Grammer K et al (2010) A neural signature of anorexia nervosa in the ventral striatal reward system. Am J Psychiatry 167(2):206–212

    PubMed  Google Scholar 

  • Fraser GL, Hoveyda HR, Tannenbaum GS (2008) Pharmacological demarcation of the growth hormone, gut motility and feeding effects of ghrelin using a novel ghrelin receptor agonist. Endocrinology 149:6280–6288

    CAS  PubMed  Google Scholar 

  • Friederich HC, Kumari V, Uher R et al (2006) Differential motivational responses to food and pleasurable cues in anorexia and bulimia nervosa: a startle reflex paradigm. Psychol Med 36:1327–1335

    PubMed  Google Scholar 

  • Fullerton DT, Swift WJ, Getto CJ et al (1986) Plasma immunoreactive beta-endorphin in bulimics. Psychol Med 16:56–63

    Google Scholar 

  • Galderisi S, Mucci A, Monteleone P et al (2003) Neurocognitive functioning in subjects with eating disorders: the influence of neuroactive steroids. Biol Psychiatry 53:921–927

    PubMed  Google Scholar 

  • Garg A (2007) Commentary: the ongoing saga of obestatin: is it a hormone? J Clin Endocrinol Metab 92:3396–3398

    CAS  PubMed  Google Scholar 

  • Gelegen C, van den Heuvel J, Collier DA et al (2008) Dopaminergic and brain-derived neurotrophic factor signalling in inbred mice exposed to a restricted feeding schedule. Genes Brain Behav 7:552–559

    CAS  PubMed  Google Scholar 

  • Gerner RH, Sharp S (1982) B-endorphin immunoreactivity in normal, schizophrenic, depressed, manic, and anorexic subjects. Brain Res 237:244–247

    CAS  PubMed  Google Scholar 

  • Gourcerol G, St-Pierre DH, Taché Y (2007) Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)? Regul Pept 141:1–7

    CAS  PubMed  Google Scholar 

  • Gross H, Ebert MH, Faden VB et al (1983) A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa before and during weight recovery. J Clin Psychopharmacol 3:165–171

    CAS  PubMed  Google Scholar 

  • Hanada T, Toshinai K, Kajimura N et al (2003) Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells. Biochem Biophys Res Commun 301:275–279

    CAS  PubMed  Google Scholar 

  • Haney M, Rabkin J, Gunderson E et al (2005) Dronabinol and marijuana in HIV+mar ijuana smokers: acute effects on caloric intake and mood. Psychopharmacology (Berl) 181:170–178

    CAS  Google Scholar 

  • Harada T, Nakahara T, Yasuhara D et al (2008) Obestatin, acylghrelin, and des-acylghrelin responses to an oral glucose tolerance test in the restricting type of anorexia nervosa. Biol Psychiatry 63:245–247

    CAS  PubMed  Google Scholar 

  • Hotta M, Ohwada R, Katakami H et al (2004) Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. J Clin Endocrinol Metab 89:5707–5712

    CAS  PubMed  Google Scholar 

  • Hotta M, Ohwada R, Akamizu T et al (2009) Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a Pilot Study. Endocr J 56:1119–1128

    CAS  PubMed  Google Scholar 

  • Janas-Kozik M, Krupka-Matuszczyk I, Malinowska-Kolodziej I et al (2007) Total ghrelin plasma level in patients with the restrictive type of anorexia nervosa. Regul Pept 140:43–46

    CAS  PubMed  Google Scholar 

  • Jerlhag E, Egecioglu E, Dickson SL et al (2007) Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbes. Addict Biol 12:6–16

    CAS  PubMed  Google Scholar 

  • Kaye WH (1996) Neuropeptide abnormalities in anorexia nervosa. Psychiatry Res 62:65–74

    CAS  PubMed  Google Scholar 

  • Kaye WH (2008) Neurobiology of anorexia and bulimia nervosa. Physiol Behav 94:121–135

    CAS  PubMed  Google Scholar 

  • Kaye WH, Pickar D, Naber D et al (1982) Cerebrospinal fluid opioid activity in anorexia nervosa. Am J Psychiatry 139:643–645

    CAS  PubMed  Google Scholar 

  • Kaye WH, Berrettini WH, Gwirtsman HE et al (1987) Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including β-endorphin) in anorexia nervosa. Life Sci 41:2147–2155

    CAS  PubMed  Google Scholar 

  • Kaye WH, Fudge JL, Paulus M (2009) New insight into symptoms and neurocircuit function of anorexia nervosa. Nature Rev Neurosci 10:573–584

    CAS  Google Scholar 

  • Kelley AE, Balski VP, Haber SN et al (2002) Opioid modulation of taste hedonics within the ventral striatum. Physiol Behav 76:365–377

    CAS  PubMed  Google Scholar 

  • Kernie SG, Liebl DJ, Parada LF (2000) BDNF regulates eating behavior and locomotor activity in mice. EMBO J 19:1290–1300

    CAS  PubMed  Google Scholar 

  • Kirkham TC, Williams CM, Fezza F et al (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136:550–557

    CAS  PubMed  Google Scholar 

  • Kissileff HR, Wentzlaff TH, Guss JL et al (1996) A direct measure of satiety disturbance in patients with bulimia nervosa. Physiol Behav 60:1077–1085

    CAS  PubMed  Google Scholar 

  • Kojima M, Hosoda H, Date Y et al (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656–660

    CAS  PubMed  Google Scholar 

  • Kojima S, Nakahara T, Nagai N et al (2005) Altered ghrelin and peptide YY responses to meals in bulimia nervosa. Clin Endocrinol (Oxf) 62:74–78

    CAS  Google Scholar 

  • Lasègue C (1873) De l’anorexie hystèrique. Arch Gèn Mèd 1:384–403

    Google Scholar 

  • Lesem MD, Berrettini WH, Kaye WH et al (1991) Measurement of CSF dynorphin A 1-8 immunoreactivity in anorexia nervosa and normal-weight bulimia. Biol Psychiatry 29:244–252

    CAS  PubMed  Google Scholar 

  • Lewin GR, Barde YA (1996) Physiology of neurotrophins. Annu Rev Neurosci 19:289–317

    CAS  PubMed  Google Scholar 

  • Lyons WE, Mamounas LA, Ricaurte GA et al (1999) Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 96:15239–15244

    CAS  PubMed  Google Scholar 

  • Malik S, McGlone F, Bedrossian D et al (2008) Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab 7:400–409

    CAS  PubMed  Google Scholar 

  • Mercader JM, Ribasès M, Gratacòs M et al (2007) Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia. Genes Brain Behav 6:706–716

    CAS  PubMed  Google Scholar 

  • Miljic D, Pekic S, Djurovic M et al (2006) Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa. J Clin Endocrinol Metab 91:1491–1495

    CAS  PubMed  Google Scholar 

  • Misra M, Miller K, Herzog D et al (2004) Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metab 89:1605–1612

    CAS  PubMed  Google Scholar 

  • Misra M, Miller KK, Stewart V (2005) Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab 90:5082–5087

    CAS  PubMed  Google Scholar 

  • Monteleone P, Martiadis V, Fabrazzo M et al (2003) Ghrelin and leptin responses to food ingestion in bulimia nervosa: implications for binge-eating and compensatory behaviours. Psychol Med 33:1387–1394

    CAS  PubMed  Google Scholar 

  • Monteleone P, Tortorella A, Martiadis V et al (2004) Opposite changes in the serum brain-derived neurotrophic factor in anorexia nervosa and obesity. Psychosom Med 66:744–748

    CAS  PubMed  Google Scholar 

  • Monteleone P, Fabrazzo M, Tortorella A et al (2005a) Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa. Psychoneuroendocrinology 30:243–250

    CAS  PubMed  Google Scholar 

  • Monteleone P, Martiadis V, Rigamonti AE et al (2005b) Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa. Biol Psychiatry 57:926–931

    CAS  PubMed  Google Scholar 

  • Monteleone P, Fabrazzo M, Martiadis V et al (2005c) Circulating brain-derived neurotrophic factor is decreased in women with anorexia and bulimia nervosa but not in women with binge-eating disorder: relationships to co-morbid depression, psychopathology and hormonal variables. Psychol Med 35:897–905

    PubMed  Google Scholar 

  • Monteleone P, Matias I, Martiadis V et al (2005d) Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. Neuropsychopharmacology 30:1216–1221

    CAS  PubMed  Google Scholar 

  • Monteleone P, Castaldo E, Maj M (2008a) Neuroendocrine dysregulation of food intake in eating disorders. Regul Pept 149:39–50

    CAS  PubMed  Google Scholar 

  • Monteleone P, Serritella C, Martiadis V et al (2008b) Deranged secretion of ghrelin and obestatin in the cephalic phase of vagal stimulation in women with anorexia nervosa. Biol Psychiatry 64:1005–1008

    CAS  PubMed  Google Scholar 

  • Monteleone P, Serritella C, Martiadis V et al (2008c) Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa. J Clin Endocrinol Metab 93:4418–4421

    CAS  PubMed  Google Scholar 

  • Monteleone P, Bifulco M, Di Filippo C et al (2009) Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects. Genes Brain Behav 8:728–732

    CAS  PubMed  Google Scholar 

  • Monteleone P, Serritella C, Scognamiglio P et al (2010) Enhanced ghrelin secretion in the cephalic phase of food ingestion in women with bulimia nervosa. Psychoneuroendocrinology 35:284–288. doi:10.1016/j.psyneuen.2009.07.001

    CAS  PubMed  Google Scholar 

  • Morley JE, Blundell JE (1988) The neurobiological basis of eating disorders: some formulations. Biol Psychiatry 23:53–78

    CAS  PubMed  Google Scholar 

  • Muller TD, Reichwald K, Bronner G et al (2008) Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa. Child Adolesc Psychiatry Ment Health 2:33–39

    PubMed  Google Scholar 

  • Murphy KG, Bloom SR (2006) Gut hormones and the regulation of energy homeostasis. Nature 444:854–859

    CAS  PubMed  Google Scholar 

  • Nagaya N, Moriya J, Yasumura Y et al (2004) Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 110:3674–3679

    CAS  PubMed  Google Scholar 

  • Nagaya N, Itoh T, Murakami S et al (2005) Treatment of cachexia with ghrelin in patients with COPD. Chest 128:1187–1193

    CAS  PubMed  Google Scholar 

  • Nakagawa T, Tsuchida A, Itakura Y et al (2000) Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes 49:436–444

    CAS  PubMed  Google Scholar 

  • Nakagawa T, Ogawa Y, Ebihara K et al (2003) Anti-obesity and anti-diabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance. Int J Obes Relat Metab Disord 27:557–565

    CAS  PubMed  Google Scholar 

  • Nakahara T, Harada T, Yasuhara D et al (2008) Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry 64:252–255

    CAS  PubMed  Google Scholar 

  • Nakai Y, Hosoda H, Nin K et al (2003) Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa. Eur J Endocrinol 149:R1–R3

    CAS  PubMed  Google Scholar 

  • Nakazato M, Hashimoto K, Shimizu E (2003) Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders. Biol Psychiatry 54:485–490

    CAS  PubMed  Google Scholar 

  • Nakazato M, Hashimoto K, Shiina A (2004) No changes in serum ghrelin levels in female patients with bulimia nervosa. Prog Neuropsychopharmacol Biol Psychiatry 28:1181–1184

    CAS  PubMed  Google Scholar 

  • Nakazato M, Hashimoto K, Yoshimura K (2006) No change between the serum brain-derived neurotrophic factor in female patients with anorexia nervosa before and after partial weight recovery. Prog Neuropsychopharmacol Biol Psychiatry 30:1117–1121

    CAS  PubMed  Google Scholar 

  • Neary NM, Small CJ, Wren AM et al (2004) Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89:2832–2836

    CAS  PubMed  Google Scholar 

  • Nedvidkova J, Krykorkova I, Bartak V (2003) Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. J Clin Endocrinol Metab 88:1678–1682

    CAS  PubMed  Google Scholar 

  • Otto B, Cuntz U, Fruehauf E (2001) Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 145:R5–R9

    CAS  Google Scholar 

  • Otto B, Tschop M, Cuntz U (2004) Similar fasting ghrelin levels in binge eating/purging anorexia nervosa and restrictive anorexia nervosa. Psychoneuroendocrinology 29:692–693

    CAS  PubMed  Google Scholar 

  • Otto B, Tschop M, Fruhauf E et al (2005) Postprandial ghrelin release in anorectic patients before and after weight gain. Psychoneuroendocrinology 30:577–581

    CAS  PubMed  Google Scholar 

  • Owen WP, Halmi KA, Gibbs J et al (1985) Satiety responses in eating disorders. J Psychiatr Res 19:279–284

    CAS  PubMed  Google Scholar 

  • Pearce JM (2004) Richard Morton: origins of anorexia nervosa. Eur Neurol 52:191–192

    CAS  PubMed  Google Scholar 

  • Pelleymounter MA, Cullen MJ, Wellman CL (1995) Characteristics of BDNF-induced weight loss. Exp Neurol 131:229–238

    CAS  PubMed  Google Scholar 

  • Prince AC, Brooks SJ, Stahl D et al (2009) Systematic review and meta-analysis of the baseline concentrations and physiological responses of gut hormones to food in eating disorders. Am J Clin Nutr 89:755–765

    CAS  PubMed  Google Scholar 

  • Schultz W, Dayan P, Montague PR (1997) A neural substrate of prediction and reward. Science 275:1593–1599

    CAS  PubMed  Google Scholar 

  • Schwartz MW, Woods SC, Porte D Jr et al (2000) Central nervous system control of food intake. Nature 404:661–671

    CAS  PubMed  Google Scholar 

  • Seoane LM, Al-Massadi O, Pazos Y et al (2006) Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats. J Endocrinol Invest 29:RC13–RC15

    CAS  PubMed  Google Scholar 

  • Simonian HP, Kresge KM, Boden GH et al (2005) Differential effects of sham feeding and meal ingestion on ghrelin and pancreatic polypeptide levels: evidence for vagal efferent stimulation mediating ghrelin release. Neurogastroenterol Motil 17:348–354

    CAS  PubMed  Google Scholar 

  • Solinas M, Justinova Z, Goldberg SR et al (2006) Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nuclear accumbens shell in rats. J Neurochem 98:408–419

    CAS  PubMed  Google Scholar 

  • Soriano-Guillen L, Barrios V, Campos-Barros A et al (2004) Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J Pediatr 144:36–42

    CAS  PubMed  Google Scholar 

  • Stock S, Leichner P, Wong AC (2005) Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab 90:2161–2168

    CAS  PubMed  Google Scholar 

  • Støving RK, Andries A, Brixen K et al (2009) Leptin, ghrelin, and endocannabinoids: potential therapeutic targets in anorexia nervosa. J Psychiatr Res 43:671–679. doi:10.1016/j.jpsychires.2008.09.007

    PubMed  Google Scholar 

  • Tanaka M, Naruo T, Muranaga T (2002) Increased fasting plasma ghrelin levels in patients with bulimia nervosa. Eur J Endocrinol 146:1–3

    Google Scholar 

  • Tanaka M, Naruo T, Yasuhara D (2003a) Fasting plasma ghrelin levels in subtypes of anorexia nervosa. Psychoneuroendocrinology 28:829–835

    CAS  PubMed  Google Scholar 

  • Tanaka M, Narau T, Nagai N et al (2003b) Habitual binge/purge behavior influences circulating ghrelin levels in eating disorders. J Psychiatr Res 37:17–22

    PubMed  Google Scholar 

  • Tanaka M, Tatebe Y, Nakahara T et al (2003c) Eating pattern and the effect of oral glucose on ghrelin and insulin secretion in patients with anorexia nervosa. Clin Endocrinol (Oxf) 59:574–579

    CAS  Google Scholar 

  • Tanaka M, Nakahara T, Kojima S et al (2004) Effect of nutritional rehabilitation on circulating ghrelin and growth hormone levels in patients with anorexia nervosa. Regul Pept 122:163–168

    CAS  PubMed  Google Scholar 

  • Tepper R, Weixman A, Apter A et al (1992) Elevated plasma immunoreactive β-endorphin in anorexia nervosa. Clin Neuropharmacol 15:387–391

    CAS  PubMed  Google Scholar 

  • Troisi A, Di Lorenzo G, Lega I et al (2005) Plasma ghrelin in anorexia, bulimia, and binge-eating disorder: relations with eating patterns and circulating concentrations of cortisol and thyroid hormones. Neuroendocrinology 81:259–266

    CAS  PubMed  Google Scholar 

  • Tsuchida A, Nonomura T, Ono-Kishino M (2001) Acute effects of brain-derived neurotrophic factor on energy expenditure in obese diabetic mice. Int J Obes Relat Metab Disord 25:1286–1293

    CAS  PubMed  Google Scholar 

  • Uehara T, Omori I, Nakamura K et al (2005) Plasma des-acyl and acyl ghrelin in patients with eating disorders. Eat Weight Disord 10:264–266

    CAS  PubMed  Google Scholar 

  • Volicer L, Stelly M, Morris J et al (1997) Effects of dronabinol on anorexia and disturbed behaviour in patients with Alzheimer’s disease. Int J Geriatr Psychiatry 12:910–919

    Google Scholar 

  • Wagner A, Aizenstein H, Venkatraman VK et al (2007) Altered reward processing in women recovered from anorexia nervosa. Am J Psychiatry 164:1842–1849

    PubMed  Google Scholar 

  • Waller DA, Kiser RS, Hardy BW et al (1986) Eating behavior and plasma beta-endorphin in bulimia. Am J Clin Nutr 44:20–23

    CAS  PubMed  Google Scholar 

  • Will MJ, Franzblau EB, Kelley AE (2003) Nucleus accumbens μ-opioids regulate intake of high-fat diet via activation of a distributed brain network. J Neurosci 23:2882–2888

    CAS  PubMed  Google Scholar 

  • Williams CM, Kirkham TC (2002) Observational analysis of feeding induced by Delta-9-THC and anandamide. Physiol Behav 76:241–250

    CAS  PubMed  Google Scholar 

  • Xu B, Goulding EH, Zang K et al (2003) Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6:736–742

    CAS  PubMed  Google Scholar 

  • Zhang JV, Ren PG, Avsian-Kretchmer O et al (2005) Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310:996–999

    CAS  PubMed  Google Scholar 

  • Zhu X, Cao Y, Voogd K et al (2006) On the processing of proghrelin to ghrelin. J Biol Chem 281:38867–38870

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Naples SUN, Largo Madonna delle Grazie, 80138, Naples, Italy

    Palmiero Monteleone

Authors
  1. Palmiero Monteleone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Palmiero Monteleone .

Editor information

Editors and Affiliations

  1. Neuroscience, Dept. Pharmacology, Rudolf Magnus Institute of, Universiteitsweg 100, Utrecht, 3508 AB, Netherlands

    Roger A.H. Adan

  2. Dept. Psychiatry, University of California, San Diego, La Jolla Drive 8950, La Jolla, 92037, California, USA

    Walter H. Kaye

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Monteleone, P. (2010). New Frontiers in Endocrinology of Eating Disorders. In: Adan, R., Kaye, W. (eds) Behavioral Neurobiology of Eating Disorders. Current Topics in Behavioral Neurosciences, vol 6. Springer, Berlin, Heidelberg. https://doi.org/10.1007/7854_2010_87

Download citation

Publish with us

Policies and ethics

Search

Navigation